Neurogene (NGNE) Institutional Ownership $16.60 -1.03 (-5.84%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Neurogene (NASDAQ:NGNE)CurrentInstitutional OwnershipPercentage52.37%Number ofInstitutional Buyers(last 12 months)25TotalInstitutional Inflows(last 12 months)$98.12MNumber ofInstitutional Sellers(last 12 months)6TotalInstitutional Outflows(last 12 months)$11.66M Get NGNE Insider Trade Alerts Want to know when executives and insiders are buying or selling Neurogene stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data NGNE Institutional Buying and Selling by Quarter Neurogene Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/27/2024Franklin Resources Inc.7,050$296K0.0%N/A0.047% 11/19/2024Barclays PLC14,859$623K0.0%+319.4%0.100% 11/16/2024Geode Capital Management LLC220,599$9.26M0.0%-0.7%1.698% 11/15/2024Barclays PLC14,859$623K0.0%+319.4%0.114% 11/15/2024Jane Street Group LLC7,717$324K0.0%N/A0.059% 11/15/2024Wellington Management Group LLP18,290$767K0.0%N/A0.141% 11/15/2024State Street Corp246,540$10.35M0.0%+17.5%1.898% 11/15/2024RTW Investments LP1,135,256$47.64M0.7%+6.0%8.739% 11/15/2024Redmile Group LLC964,347$40.46M2.4%-4.9%7.424% 11/15/2024Janus Henderson Group PLC709,469$29.78M0.0%-15.0%5.462% Get the Latest News and Ratings for NGNE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Neurogene and its competitors with MarketBeat's FREE daily newsletter. 11/14/2024Walleye Capital LLC44,500$1.87M0.0%-51.9%0.343% 11/14/2024MetLife Investment Management LLC6,054$254K0.0%N/A0.047% 11/13/2024BNP Paribas Financial Markets2,170$91K0.0%+192.8%0.017% 11/13/2024FMR LLC731,801$30.71M0.0%+912.4%5.634% 11/12/2024Charles Schwab Investment Management Inc.30,317$1.27M0.0%+2.5%0.233% 11/8/2024Jennison Associates LLC78,650$3.30M0.0%N/A0.605% 11/7/2024Quest Partners LLC1,279$54K0.0%-16.0%0.010% 10/3/2024 SG Americas Securities LLC3,576$150K0.0%N/A0.028% 8/16/2024Driehaus Capital Management LLC102,187$3.72M0.0%+123.8%0.787% 8/14/2024Marshall Wace LLP41,447$1.51M0.0%+37.2%0.319% 8/14/2024Integral Health Asset Management LLC70,000$2.55M0.2%N/A0.539% 8/14/2024Avoro Capital Advisors LLC22,029$802K0.0%N/A0.170% 8/9/2024Renaissance Technologies LLC52,807$1.92M0.0%-10.0%0.407% 8/6/2024Quest Partners LLC1,523$55K0.0%N/A0.012% 8/1/2024Rhumbline Advisers13,489$491K0.0%N/A0.104% 7/26/2024Bank of New York Mellon Corp30,428$1.11M0.0%N/A0.234% 5/16/2024Janus Henderson Group PLC813,353$41.37M0.0%-3.4%6.266% 5/16/2024Redmile Group LLC935,252$47.60M1.7%-1.2%7.205% 5/15/2024Baker BROS. Advisors LP456,015$23.21M0.3%+0.6%3.513% 5/10/2024Vanguard Group Inc.507,483$25.83M0.0%+906.5%3.943% 5/7/2024 SG Americas Securities LLC2,348$120K0.0%N/A0.018% 4/30/2024Privium Fund Management UK Ltd5,860$274K0.1%N/A0.046% 2/15/2024Great Point Partners LLC994,229$19.27M3.3%N/A42.326% 2/14/2024Avidity Partners Management LP466,243$9.04M0.3%N/A19.840% 2/2/2024BML Capital Management LLC24,666$478K0.4%N/A1.050% (Data available from 1/1/2016 forward) NGNE Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NGNE shares? During the previous two years, 30 institutional investors and hedge funds held shares of Neurogene. The most heavily invested institutionals were RTW Investments LP ($47.64M), Redmile Group LLC ($40.46M), FMR LLC ($30.71M), Janus Henderson Group PLC ($29.78M), Vanguard Group Inc. ($25.83M), Baker BROS. Advisors LP ($23.21M), and Great Point Partners LLC ($19.27M).Learn more on NGNE's institutional investors. What percentage of Neurogene stock is owned by institutional investors? 52.37% of Neurogene stock is owned by institutional investors. Learn more on NGNE's institutional investor holdings. Which institutional investors have been buying Neurogene stock? Of the 25 institutional investors that purchased Neurogene stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Great Point Partners LLC ($994.23K), FMR LLC ($659.52K), Avidity Partners Management LP ($466.24K), Vanguard Group Inc. ($457.06K), Jennison Associates LLC ($78.65K), Integral Health Asset Management LLC ($70K), and RTW Investments LP ($64.69K). How much institutional buying is happening at Neurogene? Institutional investors have bought a total of 3,065,170 shares in the last 24 months. This purchase volume represents approximately $98.12M in transactions. Which Neurogene major shareholders have been selling company stock? The following institutional investors have sold Neurogene stock in the last 24 months: Janus Henderson Group PLC ($153.66K), Redmile Group LLC ($60.96K), Walleye Capital LLC ($48K), Renaissance Technologies LLC ($5.90K), Geode Capital Management LLC ($1.46K), and Quest Partners LLC ($244.00). How much institutional selling is happening at Neurogene? Institutional investors have sold a total of 270,225 shares in the last 24 months. This volume of shares sold represents approximately $11.66M in transactions. Related Companies BCYC Major Shareholders NTLA Major Shareholders ZYME Major Shareholders RCKT Major Shareholders GYRE Major Shareholders PSTX Major Shareholders ADPT Major Shareholders OCS Major Shareholders AVXL Major Shareholders NUVB Major Shareholders This page (NASDAQ:NGNE) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTop Picks for Trump’s Pro-Crypto AmericaThe Crypto ETF Windfall: 27 Experts Tell All (Free) Don't miss your chance to see exactly what crypto's eli...Crypto 101 Media | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredTrump’s Inauguration Shocker: “Move Your Cash Now”Just in the first week after Trump's win, many stocks jumped by double and even triple digits. But now he's...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neurogene Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neurogene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NGNE Stock Alerts